# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 25021
- **Admission ID**: 133655
- **Row ID**: 3335
- **Profile Type**: FULL

## Demographics

- **Age**: 79
- **Sex**: M
- **Date of Birth**: 2023-05-03
- **Ethnicity**: BLACK/AFRICAN AMERICAN
- **Marital Status**: MARRIED
- **Religion**: NOT SPECIFIED
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2102-09-17 20:56:00
- **Discharge Date**: 2102-09-20 17:54:00

## Chief Complaint

Chest pain, acute MI

## Symptoms

- **Right-sided stabbing chest pain, non-radiating, daily for nine months, increased with mild exertion** | onset: nine months prior to admission | duration: daily for nine months | severity: mild to moderate
- **Acute onset right-sided stabbing chest pain with radiation to right shoulder** | onset: day of admission | severity: severe
- **chest pain (resolved after stenting)**

## Medical History

1. DM since 2081, no insulin; 2. DVT and PE s/p IVC filter placement; 3. BPH s/p TURP 2082 and 11-5 (complicated by DVT/PE, s/p IVC filter); 4. HTN; 5. Syncopal episode 2099, ? 'irregular heart rhythm'; 6. Erectile dysfunction

## Current Medications

- **Warfarin** | dosage: 7 mg daily | frequency: once daily | purpose: anticoagulation
- **Avandia** | dosage: 4 mg daily | frequency: once daily | purpose: diabetes control
- **Cozaar** | dosage: 100 mg daily | frequency: once daily | purpose: antihypertensive
- **Metformin** | dosage: 1500 mg daily | frequency: once daily | purpose: diabetes control
- **Omeprazole** | dosage: 20 mg daily | frequency: once daily | purpose: acid suppression

## Discharge Medications

- **ASA**
- **plavix**
- **losartan** | dosage: 50 mg qd (increased as tolerated) | frequency: once daily
- **lopressor** | dosage: 12.5 mg (increased as tolerated)
- **statin**
- **coumadin** | dosage: increase to 5 mg qd | frequency: once daily
- **avandia** | dosage: 4 mg daily | frequency: once daily
- **metformin** | dosage: 1500 mg daily | frequency: once daily

## Diagnoses

- **Acute myocardial infarction** | notes: Supported by ST-elevations and cardiac catheterization findings
- **Coronary artery disease** | notes: Multiple vessel stenoses noted on cardiac catheterization
- **Inferior myocardial infarction s/p cardiac catheterization and stenting** | notes: Patient was stable and pain free after stenting of RCA
- **Diabetes mellitus** | notes: Controlled on ISS during admission; outpatient medications held then resumed
- **Hypertension** | notes: Managed with lopressor and losartan
- **History of pulmonary embolism complicating TURP, s/p IVC filter placement** | notes: Restarted on coumadin without incident
- **Acute renal failure (baseline creatinine ~0.9)** | notes: Remained at baseline; received pericatheterization hydration

## Treatment Options

### Cardiac catheterization with PCI and stenting of right coronary artery

**Details**: Cypher stent placed in RCA

### Cardiac catheterization and stenting of RCA

**Details**: Successful rescue of RCA lesion; patient stable and pain free after procedure

### Medication management

**Details**: ASA, plavix, losartan, lopressor, statin, coumadin, SC heparin for prophylaxis

**Medications**:
- ASA (not provided)
- plavix (not provided)
- losartan (50 mg qd (increased as tolerated))
- lopressor (12.5 mg (increased as tolerated))
- statin (not provided)
- coumadin (increase to 5 mg qd)
- SC heparin (not provided)

### Diabetes management

**Details**: Held outpatient avandia and metformin; controlled on ISS during admission; resume outpatient diabetes medications at discharge

**Medications**:
- avandia (4 mg daily)
- metformin (1500 mg daily)
